{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:41:45Z","timestamp":1791200505122,"version":"4.2.0"},"reference-count":104,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/nmd.0b013e3182531f17","type":"journal-article","created":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T17:48:00Z","timestamp":1335894480000},"page":"380-387","source":"Crossref","is-referenced-by-count":16,"title":["The Increasing Frequency of Mania and Bipolar Disorder"],"prefix":"10.1097","volume":"200","author":[{"given":"Sean H.","family":"Yutzy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad R.","family":"Woofter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad M.","family":"Melhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke S.","family":"Parish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210208","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1097\/00004714-199604001-00002","article-title":"The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV.","volume":"16","author":"Akiskal","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"R2-3-20210208","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0165-0327(00)00203-2","article-title":"Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders.","volume":"59","author":"Akiskal","year":"2000","journal-title":"J Affect Disord"},{"key":"R3-3-20210208","first-page":"68","article-title":"Criteria for the soft bipolar spectrum: Treatment implications.","volume":"23","author":"Akiskal","year":"1987","journal-title":"Psychopharmacol Bull"},{"key":"R12-3-20210208","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0009-9236(96)90130-7","article-title":"Bidirectional interaction of valproate and lamotrigine in healthy subjects.","volume":"60","author":"Anderson","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"R13-3-20210208","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0165-0327(98)00142-6","article-title":"The emerging epidemiology of hypomania and bipolar II disorder.","volume":"50","author":"Angst","year":"1998","journal-title":"J Affect Disord"},{"key":"R14-3-20210208","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00004850-199300840-00001","article-title":"Current concepts of the classification of affective disorders.","volume":"8","author":"Angst","year":"1993","journal-title":"Int Clin Psychopharmacol"},{"key":"R15-3-20210208","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0165-0327(01)00429-3","article-title":"Bipolarity from ancient to modern times: conception, birth and rebirth.","volume":"67","author":"Angst","year":"2001","journal-title":"J Affect Disord"},{"key":"R17-3-20210208","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1176\/ps.2008.59.10.1175","article-title":"Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence.","volume":"59","author":"Baldessarini","year":"2008","journal-title":"Psychiatr Serv"},{"key":"R19-3-20210208","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1034\/j.1399-5618.2000.020102.x","article-title":"A plea for integrity of the bipolar disorder concept.","volume":"2","author":"Baldessarini","year":"2000","journal-title":"Bipolar Disord"},{"key":"R20-3-20210208","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1017\/S1092852900014681","article-title":"Suicide in bipolar disorder: Risks and management.","volume":"11","author":"Baldessarini","year":"2006","journal-title":"CNS Spectr"},{"key":"R21-3-20210208","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/archpsyc.57.2.187","article-title":"Does lithium treatment still work Evidence of stable responses over three decades.","volume":"57","author":"Baldessarini","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"R22-3-20210208","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1176\/ajp.156.5.811a","article-title":"Treatment delays in bipolar disorders.","volume":"156","author":"Baldessarini","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R23-3-20210208","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/1099-1077(200010)15:7<499::AID-HUP194>3.0.CO;2-3","article-title":"Efficacy and safety of novel antipsychotics: A critical review.","volume":"15","author":"Balestrieri","year":"2000","journal-title":"Hum Psychopharmacol"},{"key":"R24-3-20210208","first-page":"42","article-title":"SSRI safety in overdose.","volume":"59","author":"Barbey","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R25-3-20210208","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1176\/appi.ajp.161.1.3","article-title":"What is a mood stabilizer An evidence-based response.","volume":"161","author":"Bauer","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R27-3-20210208","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-0327(96)01421-8","article-title":"Prevalence of bipolar II disorder in outpatient depression: A 203-case study in private practice.","volume":"43","author":"Benazzi","year":"1997","journal-title":"J Affect Disord"},{"key":"R28-3-20210208","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.4088\/JCP.v64n1010","article-title":"Economic consequences of not recognizing bipolar disorder patients: A cross-sectional descriptive analysis.","volume":"64","author":"Birnbaum","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R29-3-20210208","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00019053-200725060-00006","article-title":"Costs and benefits of direct-to-consumer advertising: The case of depression.","volume":"25","author":"Block","year":"2007","journal-title":"Pharmacoeconomics"},{"key":"R31-3-20210208","first-page":"3","article-title":"Depot antipsychotic medications in bipolar disorder: A review of the literature. Acta Psychiatr Scand Suppl.","volume":"434","author":"Bond","year":"2007","journal-title":"(suppl"},{"key":"R32-3-20210208","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0893-133X(98)00025-6","article-title":"New concepts in mood stabilization: Evidence for the effectiveness of valproate and lamotrigine.","volume":"19","author":"Bowden","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"R33-3-20210208","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1176\/appi.ps.52.1.51","article-title":"Strategies to reduce misdiagnosis of bipolar depression.","volume":"52","author":"Bowden","year":"2001","journal-title":"Psychiatr Serv"},{"key":"R34-3-20210208","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.","volume":"60","author":"Bowden","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R35-3-20210208","doi-asserted-by":"crossref","first-page":"477","DOI":"10.15288\/jsa.1998.59.477","article-title":"Overdiagnosis of major psychiatric disorders in individuals with substance use disorders and personality disorders: The downside of the Woodruff principle.","volume":"59","author":"Brim","year":"1998","journal-title":"J Stud Alcohol"},{"key":"R36-3-20210208","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3109\/15563650903438566","article-title":"2008 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 26th Annual Report.","volume":"47","author":"Bronstein","year":"2009","journal-title":"Clin Toxicol (Phila)"},{"key":"R37-3-20210208","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2165\/00023210-200721120-00002","article-title":"Cognitive dysfunction in bipolar disorder: future place of pharmacotherapy.","volume":"21","author":"Burdick","year":"2007","journal-title":"CNS Drugs"},{"key":"R38-3-20210208","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5694\/j.1326-5377.1949.tb36912.x","article-title":"Lithium salts in the treatment of psychotic excitement.","volume":"2","author":"Cade","year":"1949","journal-title":"Med J Aust"},{"key":"R39-3-20210208","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0165-0327(92)90044-7","article-title":"Proposed subtypes of bipolar II and related disorders: With hypomanic episodes (or cyclothymia) and with hyperthymic temperament.","volume":"26","author":"Cassano","year":"1992","journal-title":"J Affect Disord"},{"key":"R40-3-20210208","first-page":"291","article-title":"The patient-physician covenant: An affirmation of Asklepios.","volume":"60","author":"Cassel","year":"1996","journal-title":"Conn Med"},{"key":"R41-3-20210208","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1176\/appi.ajp.161.3.414","article-title":"Lower risk for tardive dyskinesia associated with second-generation antipsychotics: A systematic review of 1-year studies.","volume":"161","author":"Correll","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R42-3-20210208","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-0327(96)00086-9","article-title":"Bipolar II disorder: A progress report.","volume":"41","author":"Coryell","year":"1996","journal-title":"J Affect Disord"},{"key":"R43-3-20210208","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1399-5618.2005.00235.x","article-title":"Safety and tolerability of emerging pharmacological treatments for bipolar disorder.","volume":"7","author":"Dunner","year":"2005","journal-title":"Bipolar Disord"},{"key":"R44-3-20210208","first-page":"31","article-title":"Heritable factors in the severity of affective illness.","volume":"11","author":"Dunner","year":"1976","journal-title":"Biol Psychiatry"},{"key":"R45-3-20210208","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1176\/appi.ajp.160.1.112","article-title":"Obesity as a correlate of outcome in patients with bipolar I disorder.","volume":"160","author":"Fagiolini","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R46-3-20210208","first-page":"37","article-title":"The incidence and prevalence of manic-melancholic syndromes in North West Wales: 1875-2005. Acta Psychiatr Scand Suppl.","volume":"433","author":"Farquhar","year":"2007","journal-title":"(suppl"},{"key":"R47-3-20210208","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archpsyc.1972.01750190059011","article-title":"Criteria for use in psychiatric research.","volume":"26","author":"Feighner","year":"1973","journal-title":"Arch Gen Psychiatry"},{"key":"R50-3-20210208","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1034\/j.1399-5618.2001.030304.x","article-title":"On defining mood stabilizer.","volume":"3","author":"Ghaemi","year":"2001","journal-title":"Bipolar Disord"},{"key":"R52-3-20210208","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/070674370204700202","article-title":"Cades disease and beyond: Misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder.","volume":"47","author":"Ghaemi","year":"2002","journal-title":"Can J Psychiatry"},{"key":"R53-3-20210208","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.4088\/JCP.v69n1110","article-title":"Overdiagnosis of bipolar disorder among substance use disorder inpatients with mood instability.","volume":"69","author":"Goldberg","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R55-3-20210208","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Evidence-based guidelines for treating bipolar disorder: Revised second edition-recommendations from the British Association for Psychopharmacology.","volume":"23","author":"Goodwin","year":"2009","journal-title":"J Psychopharmacol"},{"key":"R56-3-20210208","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.psychres.2010.06.020","article-title":"Factors associated with work, social life and family life disability in bipolar disorder patients.","volume":"186","author":"Gutierrez-Rojas","year":"2011","journal-title":"Psychiatry Res"},{"key":"R57-3-20210208","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-0327(98)00112-8","article-title":"Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP).","volume":"50","author":"Hantouche","year":"1998","journal-title":"J Affect Disord"},{"key":"R58-3-20210208","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1371\/journal.pmed.0030185","article-title":"The latest mania: selling bipolar disorder.","volume":"3","author":"Healy","year":"2006","journal-title":"PLoS Med"},{"key":"R60-3-20210208","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1212\/01.WNL.0000138424.33979.0C","article-title":"Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy.","volume":"63","author":"Hirsch","year":"2004","journal-title":"Neurology"},{"key":"R61-3-20210208","first-page":"5","article-title":"Bipolar spectrum disorder: Improving its recognition and diagnosis.","volume":"62","author":"Hirschfeld","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R62-3-20210208","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4088\/JCP.v64n0209","article-title":"Perceptions and impact of bipolar disorder: How far have we really come Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder.","volume":"64","author":"Hirschfeld","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R63-3-20210208","first-page":"5","article-title":"Recognition and diagnosis of bipolar disorder.","volume":"65","author":"Hirschfeld","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R64-3-20210208","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1176\/appi.ps.52.5.687","article-title":"Potential overdiagnosis of bipolar disorder.","volume":"52","author":"Hutto","year":"2001","journal-title":"Psychiatric services"},{"key":"R65-3-20210208","first-page":"2011","article-title":"Available at: .","volume":"5","author":"IMS Health National Sales","year":"2011","journal-title":"Accessed on January"},{"key":"R66-3-20210208","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1176\/ajp.153.8.993","article-title":"Lithium use and discontinuation in a health maintenance organization.","volume":"153","author":"Johnson","year":"1996","journal-title":"Am J Psychiatry"},{"key":"R73-3-20210208","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1399-5618.2003.00068.x","article-title":"The bipolar spectrum: A clinical perspective.","volume":"5","author":"Katzow","year":"2003","journal-title":"Bipolar Disord"},{"key":"R74-3-20210208","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-0327(01)00355-X","article-title":"Redefining mood stabilization.","volume":"73","author":"Keck","year":"2003","journal-title":"J Affect Disord"},{"key":"R75-3-20210208","first-page":"87","article-title":"Compliance with maintenance treatment in bipolar disorder.","volume":"33","author":"Keck","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"R76-3-20210208","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archpsyc.1992.01820050035005","article-title":"Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium.","volume":"49","author":"Keller","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"R77-3-20210208","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archpsyc.1992.01820100053010","article-title":"Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects.","volume":"49","author":"Keller","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"R78-3-20210208","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"R79-3-20210208","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1017\/S0033291797005333","article-title":"The epidemiology of DSM-III-R bipolar I disorder in a general population survey.","volume":"27","author":"Kessler","year":"1997","journal-title":"Psychol Med"},{"key":"R80-3-20210208","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1023\/A:1006990925122","article-title":"Metabolism and excretion of mood stabilizers and new anticonvulsants.","volume":"19","author":"Ketter","year":"1999","journal-title":"Cell Mol Neurobiol"},{"key":"R81-3-20210208","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4088\/JCP.v66n0516","article-title":"Dermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rash.","volume":"66","author":"Ketter","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R82-3-20210208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0010-440X(81)90049-3","article-title":"The spectrum of mania.","volume":"22","author":"Klerman","year":"1981","journal-title":"Compr Psychiatry"},{"key":"R83-3-20210208","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1001\/jama.293.16.1995","article-title":"Influence of patients requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.","volume":"293","author":"Kravitz","year":"2005","journal-title":"JAMA"},{"key":"R84-3-20210208","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2010.453","article-title":"Questionable antipsychotic prescribing remains common, despite serious risks.","volume":"303","author":"Kuehn","year":"2010","journal-title":"JAMA"},{"key":"R85-3-20210208","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/jat\/24.7.635","article-title":"Lamotrigine distribution in two postmortem cases.","volume":"24","author":"Levine","year":"2000","journal-title":"J Anal Toxicol"},{"key":"R86-3-20210208","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.2105\/AJPH.89.9.1328","article-title":"Public conceptions of mental illness: labels, causes, dangerousness, and social distance.","volume":"89","author":"Link","year":"1999","journal-title":"Am J Public Health"},{"key":"R87-3-20210208","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0165-0327(94)90104-X","article-title":"The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members.","volume":"31","author":"Lish","year":"1994","journal-title":"J Affect Disord"},{"key":"R88-3-20210208","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/ajem.2001.25272","article-title":"2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.","volume":"19","author":"Litovitz","year":"2001","journal-title":"Am J Emerg Med"},{"key":"R89-3-20210208","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2165\/11318850-000000000-00000","article-title":"The management of individuals with bipolar disorder: a review of the evidence and its integration into clinical practice.","volume":"69","author":"Malhi","year":"2009","journal-title":"Drugs"},{"key":"R91-3-20210208","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0010-440X(97)90089-4","article-title":"On the nature of depressive and anxious states in a family practice setting: the high prevalence of bipolar II and related disorders in a cohort followed longitudinally.","volume":"38","author":"Manning","year":"1997","journal-title":"Compr Psychiatry"},{"key":"R92-3-20210208","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nm0295-110","article-title":"Witches, multiple personalities, and other psychiatric artifacts.","volume":"1","author":"McHugh","year":"1995","journal-title":"Nat Med"},{"key":"R93-3-20210208","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.clinthera.2010.01.022","article-title":"Aripiprazole for the maintenance treatment of bipolar I disorder: A review.","volume":"32","author":"McIntyre","year":"2010","journal-title":"Clin Ther"},{"key":"R94-3-20210208","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"R96-3-20210208","first-page":"579","article-title":"Review of olanzapine in the management of bipolar disorders.","volume":"3","author":"Narasimhan","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R98-3-20210208","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4278\/0890-1171-14.1.31","article-title":"A return on investment evaluation of the Citibank, NA, health management program.","volume":"14","author":"Ozminkowski","year":"1999","journal-title":"Am J Health Promot"},{"key":"R99-3-20210208","doi-asserted-by":"crossref","first-page":"e03","DOI":"10.4088\/JCP.9058se1c.03gry","article-title":"The efficacy, tolerability, and safety of contemporary antidepressants.","volume":"71","author":"Papakostas","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"R101-3-20210208","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1176\/appi.ajp.160.7.1286","article-title":"Insurance expenditures on bipolar disorder: Clinical and parity implications.","volume":"160","author":"Peele","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R102-3-20210208","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0447.2000.tb10944.x","article-title":"Safety and tolerability considerations: Tricyclic antidepressants vs. selective serotonin reuptake inhibitors.","volume":"403","author":"Peretti","year":"2000","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"R103-3-20210208","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0010-440X(98)90080-3","article-title":"The high prevalence of soft bipolar (II) features in atypical depression.","volume":"39","author":"Perugi","year":"1998","journal-title":"Compr Psychiatry"},{"key":"R104-3-20210208","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.euroneuro.2005.04.011","article-title":"Prevalence and burden of bipolar disorders in European countries.","volume":"15","author":"Pini","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"R105-3-20210208","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/070674370404900904","article-title":"The persistence of folly: A critical examination of dissociative identity disorder. Part I. The excesses of an improbable concept.","volume":"49","author":"Piper","year":"2004","journal-title":"Can J Psychiatry"},{"key":"R106-3-20210208","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/070674370404901005","article-title":"The persistence of folly: Critical examination of dissociative identity disorder. Part II. The defence and decline of multiple personality or dissociative identity disorder. Canadian journal of psychiatry.","volume":"49","author":"Piper","year":"2004","journal-title":"Can J Psychiatry"},{"key":"R107-3-20210208","first-page":"896","article-title":"Bipolar spectrum disorders. New perspectives.","volume":"48","author":"Piver","year":"2002","journal-title":"Can Fam Physician"},{"key":"R108-3-20210208","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/archpsyc.1978.01770310017001","article-title":"Diagnosis in schizophrenia and manic-depressive illness: A reassessment of the specificity of schizophrenic symptoms in the light of current research.","volume":"35","author":"Pope","year":"1978","journal-title":"Arch Gen Psychiatry"},{"key":"R110-3-20210208","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"key":"R111-3-20210208","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1176\/ajp.126.7.983","article-title":"Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia.","volume":"126","author":"Robins","year":"1970","journal-title":"Am J Psychiatry"},{"key":"R112-3-20210208","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJMsa012075","article-title":"Promotion of prescription drugs to consumers.","volume":"346","author":"Rosenthal","year":"2002","journal-title":"N Engl J Med"},{"key":"R113-3-20210208","doi-asserted-by":"crossref","first-page":"32S","DOI":"10.1097\/00004714-199604001-00005","article-title":"Bipolar mood disorder: Practical strategies for acute and maintenance phase treatment.","volume":"16","author":"Sachs","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"R115-3-20210208","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0025-7125(05)70447-8","article-title":"Management of depression in the outpatient office.","volume":"80","author":"Salazar","year":"1996","journal-title":"Med Clin North Am"},{"key":"R116-3-20210208","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1176\/ajp.140.9.1127","article-title":"Falrets discovery: the origin of the concept of bipolar affective illness.","volume":"140","author":"Sedler","year":"1983","journal-title":"Am J Psychiatry"},{"key":"R118-3-20210208","first-page":"373","article-title":"The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program.","volume":"82","author":"Shi","year":"2004","journal-title":"J Affect Disord"},{"key":"R120-3-20210208","first-page":"422","article-title":"Diagnostic concordance between DSM-III, Feighner, and RDC.","volume":"42","author":"Singerman","year":"1981","journal-title":"J Clin Psychiatry"},{"key":"R121-3-20210208","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0091270004273680","article-title":"Origin and uses of primum non nocereabove all, do no harm!","volume":"45","author":"Smith","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"R122-3-20210208","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1176\/ajp.132.11.1187","article-title":"Clinical criteria for psychiatric diagnosis and DSM-III.","volume":"132","author":"Spitzer","year":"1975","journal-title":"Am J Psychiatry"},{"key":"R123-3-20210208","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archpsyc.1978.01770300115013","article-title":"Research diagnostic criteria: rationale and reliability.","volume":"35","author":"Spitzer","year":"1978","journal-title":"Arch Gen Psychiatry"},{"key":"R125-3-20210208","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.clinthera.2010.01.021","article-title":"Aripiprazole in schizophrenia and schizoaffective disorder: A review.","volume":"32","author":"Stip","year":"2010","journal-title":"Clin Ther"},{"key":"R126-3-20210208","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0149-2918(97)80066-5","article-title":"Fluoxetine tenth anniversary update: the progress continues.","volume":"19","author":"Stokes","year":"1997","journal-title":"Clin Ther"},{"key":"R128-3-20210208","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1176\/appi.ps.52.12.1633","article-title":"Stigma as a barrier to recovery: The extent to which caregivers believe most people devalue consumers and their families.","volume":"52","author":"Struening","year":"2001","journal-title":"Psychiatr Serv"},{"key":"R129-3-20210208","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2165\/00003495-200464150-00010","article-title":"Aripiprazole: A review of its use in schizophrenia and schizoaffective disorder.","volume":"64","author":"Swainston Harrison","year":"2004","journal-title":"Drugs"},{"key":"R130-3-20210208","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1192\/bjp.195.52.s13","article-title":"Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review.","volume":"52","author":"Taylor","year":"2009","journal-title":"Br J Psychiatry Suppl"},{"key":"R131-3-20210208","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0165-0327(00)00310-4","article-title":"Bipolar disorder in the general population in the Netherlands (prevalence, consequences and care utilisation): Results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS).","volume":"68","author":"ten Have","year":"2002","journal-title":"J Affect Disord"},{"key":"R132-3-20210208","first-page":"2011","article-title":"Available at: .","volume":"5","author":"US Department of Health and Human","year":"2011","journal-title":"Accessed on January"},{"key":"R134-3-20210208","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/schbul\/22.3.475","article-title":"Medical complications of new antipsychotic drugs.","volume":"22","author":"Umbricht","year":"1996","journal-title":"Schizophr Bull"},{"key":"R135-3-20210208","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0010-440X(77)90042-6","article-title":"Strategies of patient management in the presence of diagnostic uncertainty.","volume":"18","author":"Woodruff","year":"1977","journal-title":"Compr Psychiatry"},{"key":"R138-3-20210208","first-page":"13","article-title":"Diagnosis and management of patients with bipolar II disorder.","volume":"66","author":"Yatham","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R140-3-20210208","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/NMD.0b013e3181e084e1","article-title":"Overdiagnosis of bipolar disorder and disability payments.","volume":"198","author":"Zimmerman","year":"2010","journal-title":"J Nerv Ment Dis"},{"key":"R142-3-20210208","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4088\/JCP.08m04633","article-title":"Psychiatric diagnoses in patients previously overdiagnosed with bipolar disorder.","volume":"71","author":"Zimmerman","year":"2010","journal-title":"J Clin Psychiatry"}],"container-title":["Journal of Nervous &amp; Mental Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/NMD.0b013e3182531f17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T11:19:07Z","timestamp":1687432747000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005053-201205000-00003"}},"subtitle":["Causes and Potential Negative Impacts"],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":104,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/nmd.0b013e3182531f17","relation":{},"ISSN":["0022-3018"],"issn-type":[{"value":"0022-3018","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}